465 related articles for article (PubMed ID: 16673803)
1. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
Kasche A; Luderschmidt S; Ring J; Hein R
J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
3. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
4. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
5. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
[TBL] [Abstract][Full Text] [Related]
6. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
8. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
9. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
11. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
Yazdanyar S; Zarchi K; Jemec GBE
Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
[TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
[TBL] [Abstract][Full Text] [Related]
13. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
14. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Lee PK; Kloser A
J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
[TBL] [Abstract][Full Text] [Related]
15. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM
Acta Derm Venereol; 2005; 85(5):424-8. PubMed ID: 16159735
[TBL] [Abstract][Full Text] [Related]
17. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
18. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S
J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
20. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S
Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
